We thank Dr Ute Hamann and his colleagues (German Cancer Research Center, Molecular Genetics of Breast Cancer, B055, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany) for sharing the original data (gene frequency distribution) for p53 intron 3 duplication polymorphism and breast cancer risk. This evidence concerns the gene TP53 and breast carcinoma.